Trends in Type 2 Hypertension Among Adults

Using R with NHANES

Author

Cubicle 3253

By Survey

Crude and Age-Adjusted Prevalence of Stage 2 Hypertension by Survey Period

Data Table
Survey Period n Crude Age-Adjusted
1999-2000 4,487 18.9 (16.2-21.8) 19.8 (17.2-22.6)
2001-2002 4,945 17.8 (16.1-19.5) 18.4 (16.8-20.0)
2003-2004 4,668 18.0 (15.5-20.6) 18.0 (15.7-20.6)
2005-2006 4,693 16.7 (15.1-18.5) 16.3 (14.6-18.2)
2007-2008 5,615 15.8 (14.9-16.7) 15.4 (14.3-16.5)
2009-2010 5,988 14.1 (12.9-15.4) 13.5 (12.3-14.8)
2011-2012 5,294 14.9 (13.1-16.8) 14.0 (12.5-15.7)
2013-2014 5,641 14.5 (12.6-16.6) 13.7 (11.8-15.7)
2015-2016 5,490 16.5 (14.7-18.5) 15.2 (13.6-16.8)
2017-Mar 2020 7,948 17.0 (15.3-18.9) 15.4 (14.0-16.9)
Aug 2021-Aug 2023 6,084 15.7 (13.6-17.8) 14.2 (12.5-15.9)

By Survey & Sex

Age-Adjusted Prevalence of Stage 2 Hypertension by Survey Period & Sex

Data Table
Survey Period
Female
Male
n Percent (95% CI) n Percent (95% CI)
1999-2000 2,236 20.2 (18.1-22.4) 2,251 18.9 (15.3-22.9)
2001-2002 2,413 18.6 (16.8-20.6) 2,532 17.5 (15.7-19.5)
2003-2004 2,284 18.2 (16.3-20.2) 2,384 17.6 (14.3-21.2)
2005-2006 2,273 14.9 (13.6-16.4) 2,420 17.3 (14.9-19.9)
2007-2008 2,809 14.2 (13.2-15.4) 2,806 16.4 (14.7-18.1)
2009-2010 3,020 11.9 (10.3-13.6) 2,968 15.0 (13.8-16.3)
2011-2012 2,621 13.0 (10.8-15.5) 2,673 14.9 (13.3-16.5)
2013-2014 2,910 12.2 (10.5-14.1) 2,731 15.1 (12.5-18.1)
2015-2016 2,806 13.2 (11.4-15.2) 2,684 16.9 (14.6-19.3)
2017-Mar 2020 3,973 14.7 (13.2-16.2) 3,975 16.0 (13.9-18.3)
Aug 2021-Aug 2023 3,308 13.2 (11.4-15.3) 2,776 14.9 (12.9-17.0)

By Survey & Age Group

Prevalence of Stage 2 Hypertension by Survey Period & Age Group

Data Table
Survey Period
18 to 34
35 to 49
50 to 64
65 or More
n Percent (95% CI) n Percent (95% CI) n Percent (95% CI) n Percent (95% CI)
1999-2000 1,416 5.2 (2.3-9.9) 1,023 12.5 (9.6-15.8) 926 25.5 (22.7-28.6) 1,122 53.1 (48.0-58.2)
2001-2002 1,564 3.2 (2.2-4.5) 1,225 13.7 (11.2-16.4) 996 24.4 (20.9-28.3) 1,160 47.7 (44.0-51.4)
2003-2004 1,547 3.5 (2.1-5.6) 1,019 13.5 (10.3-17.3) 889 26.9 (22.0-32.3) 1,213 42.5 (38.0-47.1)
2005-2006 1,587 4.5 (3.2-6.2) 1,116 11.5 (8.9-14.6) 946 23.8 (19.2-28.7) 1,044 38.0 (34.8-41.2)
2007-2008 1,466 3.8 (2.9-4.9) 1,363 10.9 (8.9-13.1) 1,401 22.5 (19.6-25.5) 1,385 36.4 (31.7-41.3)
2009-2010 1,669 3.3 (2.1-4.8) 1,501 10.6 (8.6-13.0) 1,430 18.3 (15.5-21.3) 1,388 32.0 (27.9-36.2)
2011-2012 1,598 3.5 (2.8-4.4) 1,248 10.1 (7.5-13.2) 1,328 20.0 (16.2-24.3) 1,120 33.5 (30.0-37.1)
2013-2014 1,643 3.3 (2.2-4.6) 1,412 10.4 (8.2-12.9) 1,385 19.6 (15.9-23.8) 1,201 31.8 (27.7-36.1)
2015-2016 1,559 3.9 (2.8-5.3) 1,306 12.2 (10.1-14.5) 1,362 19.8 (16.7-23.1) 1,263 35.8 (30.9-40.9)
2017-Mar 2020 2,066 4.5 (3.3-6.0) 1,761 11.8 (9.4-14.6) 2,200 22.3 (18.5-26.4) 1,921 34.1 (30.2-38.2)
Aug 2021-Aug 2023 1,313 5.0 (3.8-6.4) 1,167 11.5 (8.9-14.6) 1,666 19.4 (15.9-23.3) 1,938 29.6 (27.3-32.0)

By Survey & Family Poverty Level

Age-Adjusted Prevalence of Stage 2 Hypertension by Survey Period & Family Poverty Level

Data Table
Survey Period
Less than 130%
130% to 349%
350% or more
n Percent (95% CI) n Percent (95% CI) n Percent (95% CI)
1999-2000 1,264 24.2 (19.9-29.0) 1,444 18.5 (15.8-21.4) 1,135 18.3 (14.9-22.0)
2001-2002 1,284 21.6 (18.5-24.9) 1,775 19.3 (16.6-22.3) 1,539 16.4 (14.6-18.4)
2003-2004 1,384 20.3 (17.4-23.3) 1,710 19.2 (16.2-22.6) 1,293 16.2 (13.2-19.6)
2005-2006 1,256 19.7 (16.4-23.3) 1,722 18.1 (15.8-20.5) 1,485 13.9 (12.0-16.0)
2007-2008 1,591 18.5 (16.2-20.9) 1,977 16.0 (13.8-18.5) 1,545 13.6 (12.1-15.2)
2009-2010 1,832 17.0 (14.9-19.3) 2,047 13.2 (11.8-14.6) 1,543 12.3 (10.5-14.4)
2011-2012 1,783 17.4 (15.4-19.5) 1,647 13.3 (11.2-15.7) 1,430 13.3 (11.2-15.7)
2013-2014 1,828 15.5 (12.2-19.2) 1,787 15.0 (12.7-17.7) 1,593 11.9 (9.9-14.2)
2015-2016 1,612 18.2 (15.6-20.9) 1,951 15.4 (12.7-18.4) 1,360 13.0 (9.8-16.9)
2017-Mar 2020 1,998 20.1 (16.4-24.2) 2,684 16.9 (14.9-19.0) 2,237 12.3 (10.1-14.9)
Aug 2021-Aug 2023 1,189 19.9 (16.2-23.9) 2,000 15.0 (13.4-16.6) 2,108 11.6 (9.1-14.4)